Webcast CME

Advances in Spondyloarthritis:
Translational Biology,
Classification, and Therapy

This Series has expired.  
Please click here to go to the Rheumatology Specialty Page.

Webcast Series

Print this Content

Advances in Spondyloarthritis: Translational Biology, Classification, and Therapy webcast series addresses the latest clinical research and targeted biologic therapies by compiling and critically appraising new evidence and interpreting its implications for improving the clinical management of patients with SpA. These expert faculty were featured at the Advances in Spondyloarthritis: Translational Biology, Classification, and Therapy Satellite Symposium held at the annual ACR/ARHP meeting.

Series Objectives

  1. Identify critical pathways in the axis between bone biology and innate and adaptive immunity contributing to the pathology of spondyloarthritis (SpA).
  2. List criteria and describe the clinical significance of current classifications of radiographic and nonradiographic SpA.
  3. Describe and critically appraise benefits and risk of current therapies for SpA, as well as novel agents being investigated in clinical trials.
  4. Incorporate advances in declarative knowledge of the above domains into best practices for screening, diagnosing, and managing SpA.

Target Audience

This activity is designed for rheumatologists, rheumatology fellows, rheumatology allied health professionals, and other interested health care professionals, including nurse practitioners and physician assistants.

Activity Director

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH